EF Ellerbeck, JD Mahnken, AP Cupertino, LS … - Annals of Internal Medicine, 2009 - Am Coll Physicians Effect of Varying Levels of Disease Management on Smoking Cessation. A
Randomized Trial ... EF Ellerbeck, JD Mahnken, AP Cupertino, LS Cox, KA
Greiner, LM Mussulman, N. Nazir, TI Shireman, K. Resnicow, and JS Ahluwalia ... Cited by 6 - Related articles - All 7 versions
MB Steinberg, S Greenhaus, AC Schmelzer, … - Ann Intern Med, 2009 - utmem.edu Background: Smokers with medical illnesses are at particular risk for
complications caused by tobacco. Clinical trial data on the effec- tiveness of
triple-combination pharmacotherapy for tobacco depen- dence treatment in ... Cited by 6 - Related articles - View as HTML - All 11 versions
[CITATION] Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized …
JO Ebbert, IT Croghan, A Sood, DR Schroeder … - Nicotine & Tobacco Research, 2009 - ntr.oxfordjournals.org Methods: We enrolled cigarettes smokers in an open-label, one-arm, Phase II
clinical trial to obtain preliminary data on the potential effectiveness and
safety of combination therapy with varenicline and bupropion SR for the ... Cited by 7 - Related articles - All 3 versions
ND Clinic - smokingcessationrounds.ca Tobacco dependence in those with alcohol or other substance-use disorders is
both highly prevalent and deadly. Although smoking prevalence in Canada has
decreased from 50% in 1965 to around 19% today,1 many cigarette smokers ... Related articles - View as HTML
WD van Dijk, Y Heijdra, PTJ Scheepers, JWM … - Medical Hypotheses, 2009 - Elsevier Bronchodilation diminishes the hyperinflated state of the lung and facilitates
the pulmonary deposition of cigarette smoke by deeper inhalation into the
smaller airways. Smaller particles, as in smoke, tend to penetrate and ... Related articles - All 2 versions
A PIPE, A CORÉDACTEUR, D DAVIDSON, C … - abandondutabac-conferences.ca La dépendance au tabac chez les personnes souffrant de troubles dus à l'usage
de l'alcool ou d'autres substances psychoactives est extrêmement fréquente et
mortelle. Bien que la prévalence du tabagisme au Canada ait diminué de 50 ... Related articles - View as HTML
K Kotseva, D Wood, G De Backer… - JCOM, 2009 - turner-white.com Kotseva K, Wood D, De Backer G, et al; EUROASPIRE Study Group. Cardiovascular
prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and
III surveys in eight European countries. Lancet 2009;373:929–40. Related articles
P Education - pier.acponline.org Surgeon General. The Health Benefits of Smoking Cessation: A report of the
Surgeon General. US department of Health and Human Services (DHSS), Public
Health Service (PHS), Center for Disease Control (CDC), Centre for Chronic ... Related articles - Cached - All 2 versions
CP van Schayck, DS Postma, JW Lammers - Nederlands tijdschrift voor geneeskunde, 1999 - ncbi.nlm.nih.gov At the introduction of long-acting beta 2-adrenergic agonists physicians were
reluctant to prescribe them for prolonged use, as they might increase mortality
due to asthma. In national and international guidelines beta 2-agonists are ... Cited by 2 - Related articles
